Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes.

Halme, M

Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes. [electronic resource] - International journal of radiation oncology, biology, physics Jan 1995 - 93-101 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0360-3016

10.1016/0360-3016(94)00365-R doi


Adult
Aerosols
Aged
Bronchoalveolar Lavage Fluid--cytology
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Small Cell--drug therapy
Female
Humans
Interferon-gamma--administration & dosage
Luminescent Measurements
Lung Neoplasms--drug therapy
Macrophage Activation--drug effects
Macrophages, Alveolar--physiology
Male
Middle Aged
Monocytes--physiology
Neutrophils--physiology
Reactive Oxygen Species
Recombinant Proteins
Respiratory Burst--drug effects
Time Factors